Belhaven Biopharma Inc.

Pharmaceutical company · Chapel Hill, North Carolina, United States

Belhaven Biopharma Inc. is a pharmaceutical company headquartered in Chapel Hill, North Carolina, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $32 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Belhaven Biopharma at a glance

Typepharmaceutical company

HeadquartersChapel Hill, North Carolina, United States

Earliest incorporation on record2020

SEC CIK1873965

What does Belhaven Biopharma do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $32.3 million sold (2025).

Frequently asked questions about Belhaven Biopharma

Where is Belhaven Biopharma headquartered?

Belhaven Biopharma Inc. is headquartered in Chapel Hill, North Carolina, United States.

What does Belhaven Biopharma do?

Belhaven Biopharma Inc. is a pharmaceutical company.

When was Belhaven Biopharma founded?

The earliest incorporation on record for Belhaven Biopharma Inc. is in 2020, according to public company registers.

Similar companies

Tenax Therapeutics, Inc.Chapel Hill, North Carolina, United States
Renovion, Inc.Chapel Hill, North Carolina, United States
Eldec Pharmaceuticals, Inc.Chapel Hill, North Carolina, United States
Amalgent Therapeutics, LLCChapel Hill, North Carolina, United States
Cardioxyl Pharmaceuticals IncChapel Hill, North Carolina, United States
Achelios Therapeutics, Inc.Chapel Hill, North Carolina, United States
AbbVie Inc.North Chicago, Illinois, United States
Savara IncAustin, Texas, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences